中华糖尿病杂志
中華糖尿病雜誌
중화당뇨병잡지
CHINES JOURNAL OF DLABETES MELLITUS
2010年
4期
268-271
,共4页
吴祥梅%顾愹%王知笑%查敏%杨慧%许馨予%陈恒%张梅%杨涛
吳祥梅%顧愹%王知笑%查敏%楊慧%許馨予%陳恆%張梅%楊濤
오상매%고용%왕지소%사민%양혜%허형여%진항%장매%양도
表位%T细胞%胰岛%自身抗原%1型糖尿病
錶位%T細胞%胰島%自身抗原%1型糖尿病
표위%T세포%이도%자신항원%1형당뇨병
Epitopes%T cells%Islets%Autoantigens%Type 1 diabetes mellitus
目的 应用表位多肽与人类白细胞抗原(HLA)Ⅰ类分子结合力和解离率分析建立新型T淋巴细胞表位体外筛选方法.方法 采用基于矩阵算法的SYFPEITHI和BIMAS数据库预测6种胰岛细胞自身抗原[包括谷氨酸脱羧酶65(GAD65)、胰岛素瘤相关抗原2(IA-2)、前胰岛素原(PPI)、胰岛特异性葡萄糖6-磷酸酶催化亚基相关蛋白(IGRP)、胰岛淀粉样多肽(IAPP)、神经胶质纤维酸性蛋白(GFAP)]的表位序列,根据预测的结合力指数和已有数据分析筛选并合成15个HLA-A2限制性候选表位多肽.采用HLA-A2转基因的T2细胞检测候选肽与HLA-A2的分子结合力,通过多肽/HLA复合物解离率实验分析复合物的稳定性.采用单因素方差分析进行数据统计.结果 T2细胞肽结合力分析显示,15个候选表位多肽中,IGRP152~160、IGRP215~223、IGRP228-236、PPI2~10、胰岛素B10~18、IA-2172~180、GFAP143~151与HLA-A2的分子结合力>80%.肽/HLA复合物解离率分析显示,上述结合力较强的7个表位多肽中,胰岛素B10-18、IGRP228~236、GFAP143~151、IA-2 172~180 4 h解离率低于20%.结论 本实验建立的候选多肽结合力与解离率相结合的T淋巴细胞表位体外筛选方法有助于减少研究中目标肽数量,推进1型糖尿病T淋巴细胞诊断方法的研究.
目的 應用錶位多肽與人類白細胞抗原(HLA)Ⅰ類分子結閤力和解離率分析建立新型T淋巴細胞錶位體外篩選方法.方法 採用基于矩陣算法的SYFPEITHI和BIMAS數據庫預測6種胰島細胞自身抗原[包括穀氨痠脫羧酶65(GAD65)、胰島素瘤相關抗原2(IA-2)、前胰島素原(PPI)、胰島特異性葡萄糖6-燐痠酶催化亞基相關蛋白(IGRP)、胰島澱粉樣多肽(IAPP)、神經膠質纖維痠性蛋白(GFAP)]的錶位序列,根據預測的結閤力指數和已有數據分析篩選併閤成15箇HLA-A2限製性候選錶位多肽.採用HLA-A2轉基因的T2細胞檢測候選肽與HLA-A2的分子結閤力,通過多肽/HLA複閤物解離率實驗分析複閤物的穩定性.採用單因素方差分析進行數據統計.結果 T2細胞肽結閤力分析顯示,15箇候選錶位多肽中,IGRP152~160、IGRP215~223、IGRP228-236、PPI2~10、胰島素B10~18、IA-2172~180、GFAP143~151與HLA-A2的分子結閤力>80%.肽/HLA複閤物解離率分析顯示,上述結閤力較彊的7箇錶位多肽中,胰島素B10-18、IGRP228~236、GFAP143~151、IA-2 172~180 4 h解離率低于20%.結論 本實驗建立的候選多肽結閤力與解離率相結閤的T淋巴細胞錶位體外篩選方法有助于減少研究中目標肽數量,推進1型糖尿病T淋巴細胞診斷方法的研究.
목적 응용표위다태여인류백세포항원(HLA)Ⅰ류분자결합력화해리솔분석건립신형T림파세포표위체외사선방법.방법 채용기우구진산법적SYFPEITHI화BIMAS수거고예측6충이도세포자신항원[포괄곡안산탈최매65(GAD65)、이도소류상관항원2(IA-2)、전이도소원(PPI)、이도특이성포도당6-린산매최화아기상관단백(IGRP)、이도정분양다태(IAPP)、신경효질섬유산성단백(GFAP)]적표위서렬,근거예측적결합력지수화이유수거분석사선병합성15개HLA-A2한제성후선표위다태.채용HLA-A2전기인적T2세포검측후선태여HLA-A2적분자결합력,통과다태/HLA복합물해리솔실험분석복합물적은정성.채용단인소방차분석진행수거통계.결과 T2세포태결합력분석현시,15개후선표위다태중,IGRP152~160、IGRP215~223、IGRP228-236、PPI2~10、이도소B10~18、IA-2172~180、GFAP143~151여HLA-A2적분자결합력>80%.태/HLA복합물해리솔분석현시,상술결합력교강적7개표위다태중,이도소B10-18、IGRP228~236、GFAP143~151、IA-2 172~180 4 h해리솔저우20%.결론 본실험건립적후선다태결합력여해리솔상결합적T림파세포표위체외사선방법유조우감소연구중목표태수량,추진1형당뇨병T림파세포진단방법적연구.
Objective To establish a screening method in vitro based on affinity and dissociation assay for candidate peptides of epitopes to mapping T cell epitopes of beta cell autoantigens. Methods Six islet cell autoantigens, including 65-kDa isoform of glutamic acid decarboxylase ( GAD65 ), islet antigen ( IA-2 ), preproinsulin (PPI), islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), islet amyloid polypeptide (IAPP) and glial fibrillary acidic protein (GFAP), were analyzed using SYFPEITHI and BIMAS algorithms. Fifteen peptides were identified as human leukocyte antigen( HLA)-A *0201 candidate epitopes for synthesis and screening. The peptide binding assay and temporal stability assay of peptide/HLA-A2 complexes were detected in HLA-A2 transgenic T2 cell One-way analysis of variances was used for data analysis. Results In peptide binding assays for T2 cell, 7 peptides which were IGRP152-160, IGRP215-223, IGRP228-236, PPI2-10, insulin B10-18, IA-2172-180 and GFAP143-151 showed > 80%affinity with HLA-A2 molecule. Dissociation assay showed that 4 hour-dissociation rates of insulin B10-18,IGRP228-236, GFAP143-151 and IA-2172-180 were < 20%. Conclusion This study suggests that affinity evaluation of candidate of epitope peptide with HLA molecule in vitro should consider both binding assay and dissociation assay, which would be helpful to minimize the number of target peptides in experiments and facilitate novel T cell based-diagnosis for type 1 diabetes.